Health ❯ Obesity ❯ Treatment

Medications

GLP-1 Drugs Semaglutide GLP-1 Agonists GLP-1 Therapies GLP-1 GLP-1 Receptor Agonists Weight Loss Drugs Lifestyle Changes Obesity Medications Injectable Drugs

Study Finds Weight Rebounds Within Two Years After Stopping GLP-1 Drugs

Experts call for GLP-1 therapy to be managed as long-term care for a chronic disease.

Oxford Review Finds Rapid Weight Regain After Stopping GLP-1 Drugs

FDA Approves First Wegovy Pill for Chronic Weight Management

Brazil Cracks Down on Illicit Mounjaro Sales as Lilly Launches QR Verification Tool

WHO Issues First Global Guidance Backing Long‑Term GLP‑1 Therapy for Obesity

WHO Backs Long-Term GLP-1 Use for Obesity in First Global Guideline

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

Wegovy Launches in Argentina With Adolescent Indication and Proven Cardiovascular Benefit

GLP-1 Drugs Tied to Slower Alcohol Absorption and Weaker Intoxication in Virginia Tech Pilot

Wegovy Weight-Loss Injection Launches in Argentina With Published Prices, Prescription-Only Access

Novo Nordisk Taps Eurofarma to Launch Two Weekly Semaglutide Brands in Brazil

Phase 3 Trials Show Greater Weight Loss With 7.2 mg Injection and 25 mg Oral Semaglutide

Canada Overhauls Adult Obesity Pharmacotherapy Guidelines to Personalize Treatment

Experts Explore Potential of Ozempic Microdosing for Health Beyond Weight Loss